46 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
environment, which requires us to comply with the Sarbanes-Oxley Act of 2002, and the related rules and regulations of the SEC. Company responsibilities … will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued
8-K
EX-10.1
MBRX
Moleculin Biotech Inc
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including … releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment
8-K
EX-1.1
wo2785vd
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.1
crwg1yoq9
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-1.1
4v6ch5iwv 9nn
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
8-K
EX-1.1
z0tdjhv5qw
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm